Medical Innovation Drug Safety and Pharmacovigilance @ יואל קסלר .com Homepage
Providing Valuable Resources to Healthcare Providers and Researchers
At יואל קסלר.com Homepage we aim to provide resources to assist healthcare professionals and drug safety experts. We collect and consolidate information from hundreds of professional organizations and regulatory authority websites to help promote best practice guidelines and updates on important developments in clinical medicine. We constantly update the site to provide the most up to date information. Also check out our blog with posts on other interesting topics.
We have added a regulatory page @ יואל קסלר.com which discusses good pharmacovigilance practice (GVP) guidelines including modules related to signal management, ICSR, risk management plans, risk minimization activities and more. There is also information on GCP, CTA regulations and guidance for safety monitoring in clinical trials.
Since the worldwide outbreak of COVID-19 in early 2020, information regarding its spread, symptoms, diagnosis, and treatment have grown exponentially. It is difficult to keep up with current guidelines and up to date information. We try to keep posting updated information from recognized public health organizations such as the FDA, CDC, and WHO. As well as articles published in peer-reviewed medical journals more information can be found here.
Best Practice Guidelines
It can be difficult for even the most experienced health care providers to keep track of ever changing guidelines for treatment of common diseases such as hypertension, diabetes, hyperlipidemia, etc. We aim to consolidate the guidelines from leading health organizations like the American Heart Association, World Health Organization, and the American Diabetes Association, European Society of Cardiology. More information can be found here.
Other Interesting Information at יואל קסלר .com
This page collects an assortment of interesting articles, videos, and other types of information that may be of interest to physicians, scientists, and the population at large. Some examples include information on migraine disease, neuroscience and how the brain processes music, the investigation of the use of psychedelics in the treatment of certain psychiatric disorders, and more.
Check back frequently to יואל קסלר .com Homepage for updates